Enhancing Health-related Quality of Life, Emotional Well-being and Reducing Anxiety: Integrated Psychoeducational Nursing Interventions in Patients Undergoing Modified Electroconvulsive Therapy
1 other identifier
interventional
120
1 country
1
Brief Summary
Background: Electroconvulsive Therapy (ECT) remains a highly effective intervention for severe psychiatric disorders yet concerns about cognitive and emotional side effects persist. Integrated psychoeducational psychiatric nursing intervention plays a pivotal role in mitigating these challenges, promoting patient safety, and enhancing therapeutic outcomes. So, this study aimed to evaluate the effectiveness of integrated psychoeducational psychiatric nursing intervention on health-related quality of life, emotional well-being and anxiety in patients receiving modified electroconvulsive therapy. Subjects and method: A quasi-experimental research design was utilized from January 2026 to April 2026. Setting: The study was conducted at two psychiatric inpatient hospitals in shebin elkom, Menoufia Governorate, Egypt. Subjects: A purposive sample of sixty patients was selected from the previously mentioned setting. Tools of data collection: Four valid tools were used in data collection: tool 1: A structured interview questionnaire to assess socio-demographic characteristics of the studied subjects, tool 2: The Short Form 36 Health Survey (SF-36) that measures the health-related quality of life of patients with various diseases, tool 3: The Emotional Well-Being Scale (EWBS) is a psychological assessment tool developed to evaluate individual emotional experiences and their overall affective well-being, tool 4: Beck Anxiety Inventory (BAI) to measure the severity of anxiety symptoms in adults and adolescents. Data was analyzed at two points: pre- and post-intervention. . Recommendations: Integrate psychoeducational psychiatric nursing intervention as a standard component of care for patients undergoing Modified Electroconvulsive Therapy (ECT) to enhance cognitive outcomes and emotional well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2026
CompletedFirst Submitted
Initial submission to the registry
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 12, 2026
CompletedMay 12, 2026
May 1, 2026
3 months
May 1, 2026
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in quality of life
The Short Form 36 Health Survey (SF-36) that measures the health-related quality of life of patients with various diseases higher score mean better quality of life and lower score mean low quality of life
8 weeks
Secondary Outcomes (1)
Emotional Well-Being
8 weeks
Study Arms (2)
study groups mindfulness
EXPERIMENTALwill receive the sessions, The integrated psychoeducational psychiatric nursing intervention to effectively enhances health related quality of life, emotional well-being and reduces anxiety in patients receiving modified electroconvulsive therapy
control group routine care
EXPERIMENTALwill not receive the sessions
Interventions
control group will not receive the sessions unless the study is completed
no session will be given to the control group unless all the study data collected
Eligibility Criteria
You may qualify if:
- Adults aged 18-65 years,
- diagnosed with major depressive disorder, bipolar disorder, or schizophrenia, - scheduled first time to receive MECT treatment for the first time or had not received MECT for more than six months;
- had no history of substance abuse, organic brain disease, or other severe physical illness;
- and had no contraindications for MECT, such as cardiovascular disease, intracranial hypertension, or epilepsy and able to provide informed consent.
You may not qualify if:
- Diagnosed with dementia or severe cognitive impairment, Neurological conditions affecting cognition,
- refusal to participate or inability to complete assessments, dropout, or discontinuation of MECT during the study;
- and occurrence of serious adverse events or complications during the study. .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shereenlead
- Menoufia Universitycollaborator
Study Sites (1)
Faculty of Nursing
Shibīn al Kawm, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
May 1, 2026
First Posted
May 12, 2026
Study Start
January 15, 2026
Primary Completion
April 19, 2026
Study Completion
April 22, 2026
Last Updated
May 12, 2026
Record last verified: 2026-05